Dr. Ott is part of a team at Gladstone researching SARS-CoV-2. She is working with Dr. Jennifer Doudna to develop a CRISPR-based method to rapidly measure COVID-19 RNA. By combining the technique with iPhone technology, they aim to develop a diagnostic that could deliver rapid results and be widely deployed even far from traditional labs, such as in airports and other ports of entry, and in remote communities throughout the world. More info on Gladstone’s COVID-19 research can be found here: https://gladstone.org/news/gladstone-institutes-responds-covid-19-pandemic.